期刊文献+

重组人SNX9蛋白在大肠杆菌中的表达、纯化及性质分析 被引量:3

Purification and Characterization of Recombinant Human SNX9 Protein Expressed in E.coli
下载PDF
导出
摘要 SNX9是近年发现的一种蛋白分选与转运蛋白,属于SNX家族。将原核表达载体pET-SNX9重组质粒转化大肠杆菌BL21(DE3),IPTG诱导表达可获得分子量为70kDa的融合蛋白,Western blotting结果证明此蛋白即为目的蛋白,经检测融合蛋白主要以可溶形式表达。表达产物通过亲和层析和分子筛层析两步纯化,可以获得纯度超过95%的SNX9融合蛋白。分子筛层析中蛋白的出峰体积显示SNX9融合蛋白是以二聚体形式存在。Native-PAGE和动态光散射实验均显示其具有良好的均一性。热稳定性实验表明SNX9蛋白在15℃以下基本稳定。这些信息对进一步研究SNX9的结构和功能具有重要的指导意义。 SNX9 is a novel SNX family protein, which plays important roles in protein sorting and transporting. The prokaryotic expression vector pET-SNX9 construct was transformed into E. coli BL21 (DE3) cell and induced by IPTG. The induced fusion protein (SNX9) was expressed successfully in soluble form. SDS-PAGE indicated that the molecular weight of SNX9 was about 70kDa, and the recombinant protein was confirmed by Western blotting. After affinity and gel filtration chromatography purification, the purity of SNX9 could reach over 95 %. Gel filtration elution volume suggested that SNX9 existed as a dimer in solution. Homogeneity was further confirmed by Native-PAGE and Dynamic Light Scattering (DIS) experiments. In the thermo stability experiment, SNX9 was stable below 15℃ relatively. All these information paved the way for future structural and functional study of SNX9.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2008年第8期11-17,共7页 China Biotechnology
基金 国家“863”计划资助项目(2006AA02Z173)
关键词 SORTING Nexin 9(SNX9) 可溶表达 纯化 均一性 Sorting Nexin 9 (SNX9) Soluble expression Purification Homogeneity
  • 相关文献

参考文献20

  • 1Seet L F, Hong W. The Phox (PX) domain proteins and membrane traffic. Biochlm Biophys Acta, 2006, 1761 (8): 878 - 896
  • 2Karkainen S, Hiipakka M, Wang J H, et al. Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO Rep, 2006, 7 (2): 186-191
  • 3Howard L, Nelson K K, Maciewlcz R A, et al. Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin 1 and SH3PX1. J Biol Chem, 1999, 274 (44): 31693-31699
  • 4Yeow-Fong L, Lim L, Manser E. SNX9 as an adaptor for linking synaptojanin-1 to the Cde42 effector ACK1. FEBS Lett, 2005, 579 (22) : 5040 - 5048
  • 5Lin Q, Lo C G, Cerione R A, et al. The Cdc42 target ACK2 interacts with sorting nexin 9 ( SH3PX1 ) to regulate epidermal growth factor receptor degradation. J Biol Chem, 2002, 277 (12) : 10134 -10138
  • 6Lundmark R, Carlsson S R. The β-appendages of the four adaptor-protein (AP) complexes: structure and binding properties, and identification of sorting nexin 9 as an accessory protein to AP-2. J Biol Chem, 2002, 362 ( Pt 3 ) : 597 - 607
  • 7Lundmark R, Carlsson S R. Sorting nexin 9 participates in clathrin-mediated endocytosis through interactions with the core components. J Biol Chem, 2003, 278 (47) : 46772 -46781
  • 8Lundmark R, Carlsson S R. Regulated membrane recruitment of dynamin-2 mediated by sorting nexin 9. J Biol Chem, 2004, 279 (41) : 42694 -42702
  • 9Lundmark R, Carlsson S R. Expression and properties of sorting nexin 9 in dynamin-mediated endocytosis. Methods Enzymol,2005, 404 : 545 - 556
  • 10Soulet F, Yarar D, Leonard M, et al. SNX9 regulates dynamin assembly and is required for efficient clathrin-mediated endocytosis. Mol Biol Cell, 2005, 16 (4) : 2058 -2067

同被引文献36

  • 1张伟,朱维铭,张坚,闫明文,李宁,黎介寿.酪酪肽对全肠内营养支持小鼠残留小肠代偿的影响[J].肠外与肠内营养,2008,15(1):11-15. 被引量:2
  • 2金明飞,徐伟东,黄静,金丽,王嘉,叶海峰,吴自荣.基因串联原核高效表达胸腺肽α1[J].中国生物工程杂志,2007,27(1):11-15. 被引量:10
  • 3Buchan M T,Polak J M, Capella C, et al. Electronimmunccytochemical evidence for the K-cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry, 1978, 56 ( 1 ) : 37- 44.
  • 4Brown J C, Dryburgh J R, Ross S A, et al. Identification and actions of gastric inhibitory polypeptide. Recent Prog Honn Res, 1975, 31: 487-532.
  • 5Holst J J. Gastric inhibitory polypeptide analogues : do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like peptide-1? BioDrugs, 2002, 16(3): 175-181.
  • 6Gault V A, O' Harte F P M, Flatt P R. Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential? Neuropeptides, 2003, 37(5 ) : 253-263.
  • 7Meier J J, Nauck M A, Schmidt W E, et al. Gastric inhibitory polypeptide : the neglected incretin revisited. Regulatory Peptides, 2002, 107(1-3): 1-13.
  • 8Dupre J, Ross S A, Watson D, et al. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab, 1973, 37 (5) : 826--828.
  • 9Nauck M A, Heimesaat M M, ? rskov C, et al. Preserved incretin activity of glucagon-like peptide 1 [7 - 36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest, 1993, 91( 1 ) : 301- 307.
  • 10May J M, Williams R H. The effect of endogenous gastric inhibitory polypeptide on glucose-induced insulin secretion in mild diabetes. Diabetes, 1978, 27(8) : 849-855.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部